ArticleScientific reports2023
Assessing the impact of one million COVID-19 deaths in America: economic and life expectancy losses.
Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 40 citations in OpenAlex.
- Misinformation about COVID-19 vaccines cost the United States $2 billion from hospitalizations in 2021.Health affairs scholar · 2026Article
- Atomic-Level Engineering of Synthetic Receptors for Enhanced Virus Detection and Removal.Advanced healthcare materials · 2025Article
- The financial value of improving patient access to COVID-19 antiviral therapy in Medicare Part D: A simulation study.Journal of managed care & specialty pharmacy · 2025Article
- Article
- Restoring life expectancy in low-income countries: the combined impact of COVID-19, health expenditure, GDP, and child mortality.BMC public health · 2025Article
- Burden of Acute Respiratory Infections Caused by Influenza Virus, Respiratory Syncytial Virus, and SARS-CoV-2 with Consideration of Older Adults: A Narrative Review.Infectious diseases and therapy · 2025Review
- Innovation bundles and platforms - a qualitative analysis of health system responses to the COVID-19 pandemic.BMC health services research · 2024Article
- A qualitative analysis of health service problems and the strategies used to manage them in the COVID-19 pandemic: exploiting generic and context-specific approaches.BMC health services research · 2024Article
- Lifetime cost analysis of concrete barriers and steel guardrails.Scientific reports · 2024Article
- Medical Students' Efforts to Address COVID-19 Vaccine Hesitancy Through Motivational Interviewing.Cureus · 2024Article
- Observational
- Article
- Inequalities in regional excess mortality and life expectancy during the COVID-19 pandemic in Europe.Scientific reports · 2024Article
- Article
- Pandemic preparedness requires collaboration between governments, funders and pharma.Nature medicine · 2023Article
- Can Stringent Government Initiatives Lead to Global Economic Recovery Rapidly during the COVID-19 Epidemic?International journal of environmental research and public health · 2023Article
- Pauci-immune glomerulonephritis: Post-COVID kidney disease continues to reappear, a case report.Science progressArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Between February 2020 and May 2022, one million Americans have died of COVID-19. To determine the contribution of those deaths to all-cause mortality in terms of life expectancy reductions and the resulting economic welfare losses, we calculated their combined impact on national income growth and the added value of lives lost. We estimated that US life expectancy at birth dropped by 3.08 years due to the million COVID-19 deaths. Economic welfare losses estimated in terms of national income growth supplemented by the value of lives lost, was in the order of US$3.57 trillion. US$2.20 trillion of these losses were in in the non-Hispanic White population (56.50%), US$698.24 billion (19.54%) in the Hispanic population, and US$579.93 billion (16.23%) in the non-Hispanic Black population. The scale of life expectancy and welfare losses underscores the pressing need to invest in health in the US to prevent further economic shocks from future pandemic threats.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.